Oncolytic adenovirus improves anti-tumor efficacy of adoptive T cell therapy by breaking tumor-induced immunosuppression and peripheral tolerance. (Q45906960)
Jump to navigation
Jump to search
scientific article published on 4 November 2015
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Oncolytic adenovirus improves anti-tumor efficacy of adoptive T cell therapy by breaking tumor-induced immunosuppression and peripheral tolerance. |
scientific article published on 4 November 2015 |
Statements
1 reference
Oncolytic adenovirus improves anti-tumor efficacy of adoptive T cell therapy by breaking tumor-induced immunosuppression and peripheral tolerance. (English)
1 reference
1 reference
Akseli Hemminki
1 reference
Markus Vähä-Koskela
1 reference
Susanna Grönberg-Vähä-Koskela
1 reference
Maiju Merisalo-Soikkeli
1 reference
Siri Tähtinen
1 reference
Dave Lumen
1 reference
Mikko Siurala
1 reference
4 November 2015
1 reference
1 reference
3
1 reference
Suppl 2
1 reference
P315-P315
1 reference
Identifiers
1 reference
1 reference